Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Common Stock, $0.00001 par value
-
Shares outstanding
-
120,020,745
-
Total 13F shares
-
39,079,487
-
Share change
-
+7,510,861
-
Total reported value
-
$288,764,092
-
Price per share
-
$7.39
-
Number of holders
-
95
-
Value change
-
+$36,606,178
-
Number of buys
-
61
-
Number of sells
-
27
Institutional Holders of Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value (ACRS) as of Q4 2018
As of 31 Dec 2018 Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value (ACRS) had 95 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 39,079,487 shares of stock of the company.
Largest 10 holders included DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), FRANKLIN RESOURCES INC, BlackRock Inc., D. E. Shaw & Co., Inc., FMR LLC, Sofinnova Investments, Inc., Broadfin Capital, LLC, Vivo Capital, LLC, MFN Partners Management, LP, and Rock Springs Capital Management LP.
This table shows 95 institutional shareholders of the security as of 31 Dec 2018.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.